Royal Bank Of Canada Adaptive Biotechnologies Corp Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 11,716 shares of ADPT stock, worth $79,785. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,716

Previous 11,244 4.2%

Holding current value

$79,785

Previous $40,000 47.5%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.37 - $5.12 $1,590 - $2,416	472 Added 4.2%	11,716 $59,000
Q2 2024 Aug 14, 2024	BUY	$2.34 - $3.96 $17,320 - $29,311	7,402 Added 192.66%	11,244 $40,000
Q1 2024 Nov 05, 2024	SELL	$2.88 - $4.8 $21,317 - $35,529	-7,402 Reduced 65.83%	3,842 $12,000
Q1 2024 May 15, 2024	SELL	$2.88 - $4.8 $88,251 - $147,086	-30,643 Reduced 88.86%	3,842 $12,000
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $111,117 - $171,172	32,115 Added 1355.06%	34,485 $168,000
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $62,457 - $103,972	-12,319 Reduced 83.87%	2,370 $12,000
Q2 2023 Aug 14, 2023	BUY	$6.19 - $8.78 $34,948 - $49,571	5,646 Added 62.44%	14,689 $98,000
Q1 2023 May 15, 2023	SELL	$7.8 - $10.11 $96,291 - $124,807	-12,345 Reduced 57.72%	9,043 $79,000
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $100,291 - $149,636	16,021 Added 298.51%	21,388 $163,000
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $1,625 - $3,167	250 Added 4.89%	5,367 $38,000
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $18,560 - $42,717	-2,900 Reduced 36.17%	5,117 $41,000
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $29,196 - $83,376	2,885 Added 56.22%	8,017 $111,000
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $18,374 - $26,900	-730 Reduced 12.45%	5,132 $144,000
Q3 2021 Nov 15, 2021	SELL	$30.02 - $39.87 $10,507 - $13,954	-350 Reduced 5.63%	5,862 $199,000
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $200,150 - $276,993	6,212 New	6,212 $254,000

Others Institutions Holding ADPT

# of Institutions

204

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $973M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Adaptive Biotechnologies Corp Transaction History